Zhou Liang-Fu, Mao Ying, Chen Liang
Department of Neurosurgery, Shanghai Neurosurgical Center, Huashan Hospital, Shanghai Medical College, FuDan University, Shanghai 200 040, China.
Surg Neurol. 2003 Jul;60(1):31-6; discussion 36-7. doi: 10.1016/s0090-3019(03)00190-3.
To elucidate the advances of diagnosis and surgical treatment of the cavernous sinus hemangiomas (CSHs).
The data from 20 patients with the CSHs surgically treated by authors from 1996 through 2000 was analyzed retrospectively, and a review of relevant literature was conducted.
These 20 cases accounted for 16.3% of all intracranial cavernous hemangiomas surgically treated in the same period at Huashan Hospital. The patients were aged from 32 approximately 69 years with an average age of 47 years. There were 17 females and 3 males. The common clinical manifestations were visual loss, diplopia, headache, facial numbness and extraocular muscle palsy. Computed tomography (CT) and magnetic resonance imaging (MRI) were major preoperative diagnostic modalities, but demonstrated nonspecific features. The preoperative misdiagnostic rate was 38.9%. Of the 20 patients undergoing craniotomy via modified pterional approach with or without orbitozygomatic osteotomy, tumors were removed through epidural approach (EDA) in 13 cases, intradural approach (IDA) in 7 cases. Hypotension was induced during the operation in 2 cases. Total tumor removal was achieved in 12 cases (92.3%) in the EDA group and nil in the IDA group. Incomplete tumor removal was 1 case (7.7%) in the EDA group and 7 cases (100%) in the IDA group. One patient in the IDA group died of intracranial hemorrhage postoperatively. Compared with preoperative manifestations, cranial neuropathies at discharge were worsened in 76.9% of patients in the EDA group and 83.3% of patients in the IDA group, improved in 15.4% of patients in the EDA group and 16.7% of patients in the IDA group, unchanged in 7.7% of patients in the EDA group. Follow-up study (range, 1 approximately 6 years; mean, 3 years) was available in 17 patients (89%). All patients in the EDA group improved without tumor recurrence. Nonimprovement (2 cases) and continued worsening (3 cases) occurred in the IDA group. In patients with tumor incompletely removed, the tumor enlarged in 2 cases, and unchanged or decreased in size in 3 cases, in which 2 cases underwent postoperative radiosurgery or radiotherapy. According to pathologic and MRI characteristics, the CSHs can be divided into two types, sponge-like type and mulberry-like type.
Cavernous hemangioma should be included in differential diagnosis for middle aged females with cavernous sinus tumors. Two types of the CSHs, sponge-like type and mulberry-like type, can be identified. The best microsurgical approach for the removal of the CSHs is epidural approach via the skull-base craniotomy. Radiosurgery should be considered for patients with incomplete tumor removal.
阐明海绵窦血管瘤(CSHs)的诊断及外科治疗进展。
回顾性分析1996年至2000年作者手术治疗的20例CSHs患者的数据,并对相关文献进行复习。
这20例占同期在华山医院手术治疗的所有颅内海绵状血管瘤的16.3%。患者年龄32岁至69岁,平均年龄47岁。女性17例,男性3例。常见临床表现为视力减退、复视、头痛、面部麻木及眼外肌麻痹。计算机断层扫描(CT)和磁共振成像(MRI)是主要的术前诊断方法,但表现不具特异性。术前误诊率为38.9%。20例患者采用改良翼点入路开颅术,伴或不伴眶颧截骨,13例经硬膜外入路(EDA)切除肿瘤,7例经硬膜内入路(IDA)。2例手术中采用了控制性低血压。EDA组12例(92.3%)实现肿瘤全切,IDA组无。EDA组1例(7.7%)肿瘤切除不完全,IDA组7例(100%)。IDA组1例患者术后死于颅内出血。与术前表现相比,EDA组76.9%的患者出院时颅神经病变加重,IDA组83.3%;EDA组15.4%的患者改善,IDA组16.7%;EDA组7.7%的患者无变化。17例(89%)患者获得随访(范围1年至6年;平均3年)。EDA组所有患者均改善且无肿瘤复发。IDA组出现无改善(2例)和持续恶化(3例)。肿瘤切除不完全的患者中,2例肿瘤增大,3例大小无变化或缩小,其中2例接受了术后立体定向放射外科治疗或放射治疗。根据病理及MRI特征,CSHs可分为海绵状型和桑椹状型两种类型。
中年女性海绵窦区肿瘤应考虑鉴别诊断海绵状血管瘤。CSHs可分为海绵状型和桑椹状型两种类型。切除CSHs的最佳显微手术入路是经颅底开颅的硬膜外入路。肿瘤切除不完全的患者应考虑立体定向放射外科治疗。